APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Research

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Research Report 2026

22 December 2025124 pages

Choose your research edition.

Industry ResearchDipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors include Takeda, Novartis, Merck, Eli Lilly, AstraZeneca, Mitsubishi Tanabe Pharma and Boehringer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market by Company

Takeda

Novartis

Merck

Eli Lilly

AstraZeneca

Mitsubishi Tanabe Pharma

Boehringer

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Segment by Type

Vildagliptin

Saxagliptin

Sitagliptin

Linagliptin

Others

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons) of Manufacturers (2021-2026) Table 7. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Manufacturers (2021-2026) Table 8. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue of Manufacturers (2021-2026) Table 9. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Price (US$/ton) of Manufacturers (2021-2026) Table 11. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Product Type & Application Table 14. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Takeda Company Information Table 19. Takeda Business Overview Table 20. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 21. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 22. Takeda Recent Developments Table 23. Novartis Company Information Table 24. Novartis Business Overview Table 25. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 26. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 27. Novartis Recent Developments Table 28. Merck Company Information Table 29. Merck Business Overview Table 30. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 31. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 32. Merck Recent Developments Table 33. Eli Lilly Company Information Table 34. Eli Lilly Business Overview Table 35. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 36. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 37. Eli Lilly Recent Developments Table 38. AstraZeneca Company Information Table 39. AstraZeneca Business Overview Table 40. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 41. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 42. AstraZeneca Recent Developments Table 43. Mitsubishi Tanabe Pharma Company Information Table 44. Mitsubishi Tanabe Pharma Business Overview Table 45. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 46. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 47. Mitsubishi Tanabe Pharma Recent Developments Table 48. Boehringer Company Information Table 49. Boehringer Business Overview Table 50. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 51. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 52. Boehringer Recent Developments Table 53. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 54. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2021-2026) & (k tons) Table 55. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2021-2026) Table 56. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2027-2032) & (k tons) Table 57. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2027-2032) Table 58. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2021-2026) Table 60. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2027-2032) Table 62. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (k tons) Table 64. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2027-2032) & (k tons) Table 65. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 66. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 67. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (k tons) Table 69. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2027-2032) & (k tons) Table 70. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 71. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 72. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (k tons) Table 74. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2027-2032) & (k tons) Table 75. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 76. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 77. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (k tons) Table 79. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2027-2032) & (k tons) Table 80. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 81. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 82. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (k tons) Table 84. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2027-2032) & (k tons) Table 85. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 86. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 87. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (k tons) Table 88. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2027-2032) & (k tons) Table 89. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2021-2026) Table 90. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2027-2032) Table 91. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 92. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 93. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2021-2026) Table 94. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2027-2032) Table 95. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2021-2026) & (US$/ton) Table 96. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2027-2032) & (US$/ton) Table 97. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (k tons) Table 98. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2027-2032) & (k tons) Table 99. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2021-2026) Table 100. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2027-2032) Table 101. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 102. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 103. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2021-2026) Table 104. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2027-2032) Table 105. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2021-2026) & (US$/ton) Table 106. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2027-2032) & (US$/ton) Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors List Table 110. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Customers List Table 111. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Trends Table 112. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Drivers Table 113. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Restraints Table 114. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Image Figure 5. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 7. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (2021-2032) & (k tons) Figure 8. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Price (US$/ton) & (2021-2032) Figure 9. Vildagliptin Product Image Figure 10. Saxagliptin Product Image Figure 11. Sitagliptin Product Image Figure 12. Linagliptin Product Image Figure 13. Others Product Image Figure 14. Hospital Pharmacies Product Image Figure 15. Online Pharmacies Product Image Figure 16. Retail Pharmacies Product Image Figure 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region in 2025 Figure 23. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region in 2025 Figure 24. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country in 2025 Figure 25. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2021-2032) Figure 26. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2021-2032) Figure 27. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country in 2025 Figure 31. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2021-2032) Figure 32. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2021-2032) Figure 33. Germany Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country in 2025 Figure 44. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2021-2032) Figure 46. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country in 2025 Figure 55. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2021-2032) Figure 56. South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2021-2032) Figure 57. Brazil Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country in 2025 Figure 61. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Country (2021-2032) Figure 63. Egypt Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2021-2032) Figure 69. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2021-2032) Figure 70. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (US$/ton) by Type (2021-2032) Figure 71. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2021-2032) Figure 72. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2021-2032) Figure 73. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price (US$/ton) by Application (2021-2032) Figure 74. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Value Chain Figure 75. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Opportunities and Challenges

Scope & coverage.

Types
  • Vildagliptin
  • Saxagliptin
  • Sitagliptin
  • Linagliptin
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Takeda
  • Novartis
  • Merck
  • Eli Lilly
  • AstraZeneca
  • Mitsubishi Tanabe Pharma
  • Boehringer

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size (2021-2032)
  4. 2.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (2021-2032)
  5. 2.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Average Price (2021-2032)
  6. 2.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Vildagliptin
  9. 2.3.3 Saxagliptin
  10. 2.3.4 Sitagliptin
  11. 2.3.5 Linagliptin
  12. 2.3.6 Others
  13. 2.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Hospital Pharmacies
  16. 2.4.3 Online Pharmacies
  17. 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons) of Manufacturers (2021-2026)
  3. 3.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Product Type & Application
  8. 3.8 Global Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Established Date
  9. 3.9 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Takeda
  2. 4.1.1 Takeda Company Information
  3. 4.1.2 Takeda Business Overview
  4. 4.1.3 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  6. 4.1.5 Takeda Recent Developments
  7. 4.2 Novartis
  8. 4.2.1 Novartis Company Information
  9. 4.2.2 Novartis Business Overview
  10. 4.2.3 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  12. 4.2.5 Novartis Recent Developments
  13. 4.3 Merck
  14. 4.3.1 Merck Company Information
  15. 4.3.2 Merck Business Overview
  16. 4.3.3 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  18. 4.3.5 Merck Recent Developments
  19. 4.4 Eli Lilly
  20. 4.4.1 Eli Lilly Company Information
  21. 4.4.2 Eli Lilly Business Overview
  22. 4.4.3 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  24. 4.4.5 Eli Lilly Recent Developments
  25. 4.5 AstraZeneca
  26. 4.5.1 AstraZeneca Company Information
  27. 4.5.2 AstraZeneca Business Overview
  28. 4.5.3 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  30. 4.5.5 AstraZeneca Recent Developments
  31. 4.6 Mitsubishi Tanabe Pharma
  32. 4.6.1 Mitsubishi Tanabe Pharma Company Information
  33. 4.6.2 Mitsubishi Tanabe Pharma Business Overview
  34. 4.6.3 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  36. 4.6.5 Mitsubishi Tanabe Pharma Recent Developments
  37. 4.7 Boehringer
  38. 4.7.1 Boehringer Company Information
  39. 4.7.2 Boehringer Business Overview
  40. 4.7.3 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  42. 4.7.5 Boehringer Recent Developments
5 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Scenario by Region
  1. 5.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region: 2021-2032
  3. 5.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region: 2021-2026
  4. 5.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region: 2027-2032
  5. 5.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region: 2021-2032
  6. 5.3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region: 2021-2026
  7. 5.3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region: 2027-2032
  8. 5.4 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country
  9. 5.4.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2032)
  11. 5.4.3 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country
  16. 5.5.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2032)
  18. 5.5.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country
  41. 5.7.1 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2032)
  43. 5.7.3 South America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2032)
  2. 6.1.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2032) & (k tons)
  3. 6.1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2021-2032)
  4. 6.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2032)
  5. 6.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2032)
  2. 7.1.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2032) & (k tons)
  3. 7.1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2021-2032)
  4. 7.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2032)
  5. 7.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Value Chain Analysis
  2. 8.1.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Mode & Process
  5. 8.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors
  8. 8.2.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Customers
9 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Analyzing Market Dynamics
  1. 9.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Trends
  2. 9.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Drivers
  3. 9.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Opportunities and Challenges
  4. 9.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst